Jump to main content
Jump to site search

Issue 8, 2017
Previous Article Next Article

In situ synthesis of Prussian blue nanoparticles within a biocompatible reverse micellar system for in vivo Cs+ uptake

Author affiliations

Abstract

A new highly stable Prussian blue reverse micellar system comprising ultra-small Prussian blue nanoparticles in Aonys® (Peceol™, β-sitosterol, lecithin, ethanol and water) acts as an in vivo Cs+ uptake agent presenting higher efficiency compared to commercially available Prussian blue treatment with a significant dose effect.

Graphical abstract: In situ synthesis of Prussian blue nanoparticles within a biocompatible reverse micellar system for in vivo Cs+ uptake

Back to tab navigation

Supplementary files

Article information


Submitted
02 Dec 2016
Accepted
03 Mar 2017
First published
15 Mar 2017

New J. Chem., 2017,41, 2887-2890
Article type
Letter

In situ synthesis of Prussian blue nanoparticles within a biocompatible reverse micellar system for in vivo Cs+ uptake

C. Lavaud, M. Kajdan, E. Compte, J. Maurel, J. Lai Kee Him, P. Bron, E. Oliviero, J. Long, J. Larionova and Y. Guari, New J. Chem., 2017, 41, 2887
DOI: 10.1039/C6NJ03770D

Social activity

Search articles by author

Spotlight

Advertisements